Close
Close
Close
Close
Close
Close

Our diverse portfolio helps us deliver on our commitment to Women's Health

8 March 2021

Theramex is a proud supporter of International Women’s Day

“At Theramex, there is a recognition that not only diversity, but a gender-equal workforce brings in a wealth of benefits and value to our business.” Anjuna Kalsi, Chief Human Resources Officer

This International Women’s Day is the fourth which Theramex has participated in since the company’s inception in 2018. Our work takes us across the evolving needs of women as they move through different stages in their lives. From contraception to fertility, menopause to osteoporosis, women are our patients and our passion. Our involvement in International Women’s Day provides an important opportunity to reinforce that our work is more of a duty than a job and we are working to improve the lives of women across the globe. International Women’s Day is the fulcrum of Theramex’s Corporate Social Responsibility as well as a focus for some of our employee engagement initiatives. Each year we are committed to celebrate and support the social, economic, cultural, and political achievements of women.

This year’s International Women’s Day theme #ChooseToChallenge resonates with Theramex’s culture. A culture where we are constantly challenging taboos relating to women’s health such as infertility and menopause through awareness and conversations around these important topics which affect women’s health. Our commitment to ‘helping women to live better lives’ remains constant. For this year’s International Women’s Day, we are partnering with Binti International, a UK based charity whose mission is to provide menstrual dignity to all girls all over the world.

Check out our fundraising page to help support this fantastic cause: https://uk.virginmoneygiving.com/Theramex. All donations, big or small will make a difference to a girl’s life!

#IWD2021 #ChooseToChallenge #Binti #TheramexIWD2021

15 March 2021

Theramex’s response to the UK government’s call for evidence to improve health and wellbeing of women in England

Read more

2 March 2021

EU & UK conclude Decentralised Procedure approval for Bijuva® (Estradiol & Progesterone) capsules for hormone replacement therapy

Read more